Join AbbVie scientists Shitalben Patel and Jami R. Erickson as they showcase their innovative advancements, transforming CETSA® into a high-throughput flow-based platform and introducing new whole blood formats to elevate drug discovery.
In this webinar, you’ll learn about flow-based CETSA, a powerful, high-throughput technique that enables single-cell target engagement analysis without cell lysis. Designed for screening of large compound libraries, this method overcomes traditional limitations like low throughput and high cell input. You will also hear how the method is being integrated into real-world SAR funnels to accelerate hit generation.
